Creston Health rebrands as Health Unlimited
pharmafile | November 18, 2014 | News story | Medical Communications | Astellas, Creston, Red Door, health unlimited, warne
Marketing communications group Creston has announced that its Creston Health arm will now be rebranded as Health Unlimited.
Under the new branding, Creston’s health marketing communications companies aim to work more collaboratively and have access to each other’s resources in order to give clients entrance to a range of sectors under a single legal framework agreement.
“With a shared creative philosophy, common tools and the promise of unlimited thinking at its core, Health Unlimited brings together consultants and discipline experts from across the Creston Group and beyond,” the company says in a statement.
“Through this, clients gain access to a diverse and complementary range of integrated technology, brand and consultancy services: from advertising and PR, through social and digital marketing to the latest research, insight and tech innovation.”
As part of the launch, all Creston Health (now Health Unlimited) companies will be rebranded with the ‘Unlimited’ suffix. This includes PR company Red Door Communications, advertising agency PAN, and medical communications agency Rock – now Red Door Unlimited, Pan Unlimited, and Rock Unlimited respectively.
All the companies will continue to operate as standalone businesses servicing clients in their core markets and disciplines, while playing a full part in Health Unlimited.
“The inclusion of Unlimited across Creston company names and brands signifies a common creative philosophy and the capability to work together as one,” the firm adds.
Debra Jux, associate director of procurement and business unit lead at Astellas Europe, says: “This is one of the models which we’re now looking for in our agency partners. From our perspective in the health sector, it is hugely attractive to be able to easily tap into other sectors to inspire innovative thinking and ensure that we benefit from the ‘latest’ competitive advantage.”
Creston as a whole has rebranded as Creston Unlimited, although the name of its holding company, Creston plc, remains unchanged.
George Underwood
Related Content
Astellas and Elpiscience enter collaboration for novel bispecific macrophage engager
Elpiscience Biopharma and Astellas Pharma have announced that they have entered into a research collaboration …
EMA accepts Astellas’ MAA for Zolbetuximab
Astellas Pharma has announced that the European Medicines Agency (EMA) has accepted the company’s marketing …
Astellas and Cullgen enter into $1.9bn strategic collaboration to progress protein degraders
Japanese pharmaceutical company Astellas and US-based clinical-stage biopharmaceutical company Cullgen have announced that they have …
